Júlio César Teixeira

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

Diane M. Harper, Eduardo L. Franco, Cosette M. Wheeler et al. · The Lancet · 2004 · 1.6K citations

Vaccination, Vaccine Safety, Vaccine Development +6

Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

Matti Lehtinen, Jorma Paavonen, Cosette M. Wheeler et al. · The Lancet Oncology · 2011 · 693 citations

Vaccination, Cervical Cancer Screening, Hpv-16/18 As04-adjuvanted Vaccine +14

Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

Cosette M. Wheeler, Xavier Castellsagué, Suzanne M. Garland et al. · The Lancet Oncology · 2011 · 499 citations

Vaccination, Vaccine Safety, Cervical Cancer Screening +14

Efficacy of a Bivalent L1 Virus-Like Particle Vaccine in Prevention of Infection With Human Papillomavirus Types 16 and 18 in Young Women: A Randomized Trial

Diane M. Harper, Eduardo L. Franco, Cosette M. Wheeler et al. · Obstetrical & Gynecological Survey · 2005 · 247 citations

Immunology, Gynecology, Hpv Infection +27

Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine

Paulo Naud, Cecília Roteli-Martins, Newton Sérgio de Carvalho et al. · Human Vaccines & Immunotherapeutics · 2014 · 245 citations · Full text